Translational Development Acquisition Corp.
NASDAQ:TDACShell Companies
-$0.01 today
- Market cap
- $267.99M
- Beta
- 0.01
- P/E (TTM)
- 29.8
- EPS (TTM)
- $0.36
Volume 0.47M
Average 0.10M
TDAC Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Translational Development Acquisition Corp.NASDAQ: TDAC
Total Assets · Q1 FY2026 · quarter ended Mar 2026
Total assets rises 3.8% from a year ago
Total assets stood at $183.35M at the end of Q1 FY2026, up 3.8% from a year earlier and up 0.9% from the prior quarter. Over 3 fiscal years it compounded at +646.2% a year.
Context
- Total assets increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total assets keeps rising in the next quarterly balance sheet after a +3.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 181.7M USD
- Year-over-year change
- +3.8%
- 3-year CAGR
- +646.2%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 181.7M | +3.8% |
| FY2024 | 2024-12-31 | 175M | +8659008.3% |
| FY2023 | 2023-12-31 | 2.02K | -99.5% |
| FY2022 | 2022-12-31 | 437.24K | — |
Total Assets vs competitors
How TDAC compares with its peers on the latest reported figures
- TDAC's Mar 2026 total assets of $183.35M is the 5th highest of the 7 companies compared; the peer median is $184.96M.
- Its year-over-year change of +3.8% is the 4th highest of 6, against a peer median of +4.0%.
- Over three fiscal years its annual growth of +646.2% compares with a peer median of +14.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Mar 2026 | $239.81M | +85794.2% | +14.0% | |
| Mar 2026 | $209.61M | +4.0% | +3121.7% | |
| Mar 2026 | $185.82M | +3.3% | -19.2% | |
NTWONewbury Street II Acquisition Corp | Mar 2026 | $184.11M | +3.6% | — |
| Mar 2026 | $183.35M | +3.8% | +646.2% | |
MACIMelar Acquisition Corp. I | Mar 2026 | $176.93M | +5.9% | — |
| Jun 2025 | $417.68K | — | — | |
| Peer median (excluding TDAC) | $184.96M | +4.0% | +14.0% | |
Competitors are the stored peer set for TDAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Translational Development Acquisition Corp.
NASDAQ:TDAC
Intrinsic Alpha fair value
Locked
Current Price
$10.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.